The International Agency for Research on Cancer (IARC) of the World Health Organization has classified hepatitis D virus (HDV) as carcinogenic, citing sufficient evidence and placing it alongside hepatitis B virus (HBV) and hepatitis C virus (HCV) as a cause of hepatocellular carcinoma (HCC).

WHO’s classification of hepatitis D virus as carcinogenic raises urgent questions for vaccination, screening, and treatment strategies worldwide.